Mutations in the transforming growth factor beta type II receptor (TGFb RII) gene have been detected in several human cancers exhibiting microsatellite instability. To extend analyses of this gene, we previously investigated the exon-intron organization of the TGFb RII gene and de®ned seven exons and¯anking intron sequences. In this study, we further determined the nucleotide sequences surrounding these seven exons and designed eight sets of intron-based primers to examine the entire coding region of the TGFb RII gene. Using these primers, we screened genomic DNA sequences from 30 sporadic colorectal cancers for mutations of the TGFb RII gene. TGFb RII mutations were detected in two of 30 tumors and both displayed microsatellite instability. One had a deletion in a polyadenine tract in exon 3 and the other had a point mutation in the kinase domain located in exon 7. There were no mutations in exons 1, 2, 4, 5 and 6. These results further implicate the polyadenine tract and kinase domain as mutational hotspots in the TGFb RII gene in cells with genomic instability and suggest that TGFb RII gene mutations occur rarely in cells lacking genomic instability.
Introduction
Mutations in the TGFb RII gene were reported recently to occur in human cancers of the colon Lu et al., 1995; Parsons et al., 1995) , stomach (Park et al., 1994) , endometrium , and head and neck (GarrigueAntar et al., 1995) . These and other observations are consistent with the hypothesis that TGFb RII is a tumor suppressor gene whose mutational inactivation is important in human carcinogenesis (Sun et al., 1994; Wang et al., 1995) .
Mutations in the TGFb RII gene found to date have clustered in domains IX and XI (codons 505 ± 544) of the kinase region Garrigue-Antar et al., 1995; Hanks et al., 1988) and in two microsatellites at codons 125 ± 128 and 532 ± 534 in colon, gastric and endometrial cancers with microsatellite instability Myero et al., 1995) . Most studies have analysed either cancer cell lines or frozen tumor series which can generate cDNA for PCR-based analysis. Lack of the TGFb RII genomic sequence has been a signi®cant impediment to the mutation analysis of genomic DNA because exon primers frequently straddle introns and fail to generate useful products. Since the spectrum and frequency of such mutations leading to the inactivation of the TGFb RII gene are not known in sporadic cancers, we previously determined the genomic sequence of the TGFb RII gene in order to produce intron-based primers for mutation analysis (Takenoshita et al., 1966; Hagiwara and Harris, 1996) . We found that the TGFb RII protein is encoded by 567 codons distributed in seven exons (Takenoshita et al., 1996) . In this study, we determined the intron sequences¯anking the seven exons and produced eight intron based primer pairs for mutation analysis of the entire coding region of the TGFb RII gene. Since previous studies of colorectal cancer have focused on tumors with MI Lu et al., 1995; Parsons et al., 1995) , we analysed 30 sporadic colorectal cancers by PCR ± SSCP and DNA sequencing for mutations in the TGFb RII gene in genomic DNA samples.
Thirty colorectal tumors and corresponding normal tissues were obtained from 26 patients with sporadic colorectal cancer. None of these patients had features suggesting hereditary non-polyposis colorectal carcinoma (HNPCC), though one patient had ®ve independent colorectal tumors. Genomic DNA was prepared by proteinase K treatment and phenol-chloroform extraction using a standard method.
We previously determined the genomic structure of the TGFb RII gene by two PCR-based methods (Takenoshita et al., 1996) . In this study, we further determined the nucleotide sequences of¯anking introns for all seven exons by the same methods (Figure 1) . We also designed and tested intron primers for PCR ± SSCP analysis of all exons of the TGFb RII gene (Table 1) . This analysis identi®ed two mutations in two cases.
In case 2006, an SSCP variant was detected in exon 3 ( Figure 2a ). Sequence analysis de®ned a two base deletion in the polyadenine tract (Figure 3a ), resulting in a frameshift in the cysteine-rich extracellular domain . Altered mobility was also seen in exon 7 in one of ®ve independent colorectal cancers, 3003, from a patient with multiple colorectal cancers (Figure 2b ), and a G to A transition at codon 528 in exon 7 substituted an arginine for histidine (Figure 3b ). This mutation fell within the highly conserved serine/ threonine protein kinase catalytic domain XI (Garrigue-Antar et al., 1995) .
To investigate the relationship between genomic instability and the occurrence of TGFb RII gene mutations, we reviewed the results of our previous studies on MI (Ishimaru et al., 1995) . Twenty-®ve tumors from 25 patients were analysed for microsatellite instability (MI) by PCR ampli®cation of six simple repeated sequences: RB intron 21, D14S65, D14S78, LPL, D3S1284, D8s167, RB intron 20, and p53 intron 1. MI was detected in six of 25 tumors; three tumors (2006, 2022 and 2055) had MI at two or more loci. In particular, additional bands were observed at ®ve of the six loci in tumor 2006. Since we have not examined for MI in ®ve independent colorectal tumors (3001 ± 3005) arising in a single patient, we analysed RER at eight microsatellite loci (D3S1284, D5S421, D8S167, D9S162, D14S655, Table 1 . Fifty ng of genomic DNA suspended in a total volume of 20 ml PCR reaction buer containing 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 1.5 mM MgCl 2 , 100 nM of each primer, 200 mM of each deoxynucleotide triphosphate, 1.5 mCi of [a-32 P]dCTP (Amersham), and 0.5 unit of Taq DNA polymerase (Pharmacia Biotech). The PCR conditions were as follows; 60 s at 948C, 60 s at 558C or 608C and 90 s at 728C for 35 or 40 cycles, followed by 10 min at 728C. The PCR products were then denatured, cooled on ice, loaded on neutral 5% polyacrylamide gels with and without 5% (vol/vol) glycerol, electrophoresed at 158C, dried and exposed to Kodak XAR ®lms for 24 ± 48 h at 7808C TGFb IIR mutations in sporadic colorectal carcinoma S Takenoshita et al D14S78, p53 intron 1 and DCC) in these tumors. RER was detected at multiple loci in all of ®ve independent tumors (Figure 4) , suggesting the presence of genomic instability in this patient. Thus, TGFb RII gene mutations were detected only in tumors with genomic instability represented by the RER phenotype. Mutational inactivation of the TGFb RII gene occurs in 76 ± 89% of colorectal cancers with microsatellite instability , 71% of gastric cancers with MI, 17% of endometrial tumors MI , and in two of nine (22%) squamous cancer cell lines (Garrigue-Antar et al., 1995) . To de®ne the role of TGFb RII mutations in the pathogenesis of human cancer, analysis of a spectrum of cancers is needed. For this purpose, we determined the genomic structure of the TGFb RII gene (Takenoshita et al., 1996) . In this study, we further de®ned the intronic sequences and developed PCR primers suitable for ampli®cation of genomic DNA. Using eight sets of primers, we ampli®ed the entire coding region of the gene. Then we performed PCR ± SSCP analysis of all coding and splice site sequences of the TGFb RII gene in 30 sporadic colorectal cancers to determine the frequency and location of TGFb RII mutations.
Mutations were detected in two of 30 tumors (6.7%), and both tumors showed MI. Case 2006 has a two-base deletion in a poly-A 10 tract at nucleotides 709 to 718, and case 3003 has a missense mutation in the kinase domain at nucleotide 1977. Previously it was shown that mutations occur not only in two microsatellites but also in the kinase domain of the TGFb RII gene. Although exon 7 contains two copies of the (GT) 3 microsatellite which are commonly mutated Parsons et al., 1995) , no mutation was detected in these regions. Furthermore, in spite of , a G to A transition at codon 528 in exon 7 was detected and resulted in a substitution of arginine for histidine. The normal sequence is displayed in lane N. DNA fragments with mobility shifts were excised from the dried gels and reampli®ed by PCR using the corresponding set of primers for 45 cycles. Ampli®ed DNA fragments were puri®ed by phenol-chloroform extraction and ethanol precipitation and cloned into the pCRII vector using the TA Cloning System (Invitrogen) according to the manufacturer's protocol. The insert was sequenced using the AutoRead Sequencing Kit with the A.L.F. DNA sequencer II (Pharmacia Biotech) and the fmol DNA Sequencing System (Promega) with 6% denaturing polyacrylamide gel N  T1  T2 T3  T4  T5   N T1  T2  T3  T4 extensive analysis for mutations in other coding regions, no mutations were detected in exons 1, 2, 4, 5 and 6, suggesting that TGFb RII gene mutations occur in highly restricted genomic regions in colorectal carcinoma. Similar to the previous results our results also indicate that TGFb RII mutations are tightly linked to MI and occur infrequently in sporadic colorectal cancers. The data presented here will contribute to an understanding of the function of the TGFb RII gene product and its role in development of colorectal cancers with MI. Our data will also assist eorts to apply PCR-based protocols to the screening of genomic DNAs for mutations in the TGFb RII gene in a variety of human cancers.
Abbreviations ng, nanogram; TGFb RII, transforming growth factor type II receptor; MI, microsatellite instability; PCR, polymerase chain reaction; RER, replication error.
